[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335896-105":59,"doc-detail-335896-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","historical-perspective-and-future-directions-computational-science-in-immuno-oncology-review","Historical perspective and future directions: computational science in immuno-oncology - review","","Immuno-oncology promises durable clinical responses across many advanced and metastatic cancers, yet only a minority of patients benefit, making mechanisms of response and resistance essential for guiding treatment selection. Advances in molecular sequencing have created vast genomic and transcriptomic datasets that enable computational interrogation of tumor-immune interactions. The review surveys existing and emerging computational methods for characterizing the tumor microenvironment, inferring immune reactivity and clonal dynamics, and predicting antigenic landscapes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/historical-perspective-and-future-directions-computational-science-in-immuno-oncology-review/335896/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/historical-perspective-and-future-directions-computational-science-in-immuno-oncology-review/335896.png","ImageObject",300,407,{"name":92,"@type":93},"Logic","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is understanding immunotherapy response and resistance important in immuno-oncology?","Question",{"text":112,"@type":113},"Only a minority of patients respond to immunotherapy, so clarifying molecular mechanisms of response and resistance is needed to improve treatment development and selection.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does computational science use sequencing data in immuno-oncology?",{"text":117,"@type":113},"Next-generation sequencing generates large genomic and transcriptomic datasets that can be mined with computational tools to uncover complex tumor-immune interactions.",{"name":119,"@type":110,"acceptedAnswer":120},"What does the review highlight about multi-omics and AI approaches?",{"text":121,"@type":113},"It emphasizes the advantage of multi-omics analyses to capture multidimensional relationships and AI techniques to integrate omics data with histopathological and radiological images for understanding treatment response and tumor-immune biology.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335896,1791218185,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","Open access Review  \n Historical perspective and future  \ndirections: computational science in immuno-oncology  \nCora A Ricker  ,1 Kevin Meli  ,1,2 Eliezer M Van Allen  1  \nTo cite: Ricker CA, Meli K, Van Allen EM. Historical perspective and future directions: computational science in immuno-oncology. Journal for ImmunoTherapy of Cancer 2024;12:e008306 . doi:10 . 1136/ jitc-2023-008306  \n► Additional supplemental material is published online only. To view, please visit the journal online ([http://dx.doi.org/10](http://dx.doi.org/10) . 1136/jitc-2023-008306) .  \nAccepted 07 December 2023  \n© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.  \n1Medical Oncology, DanaFarber Cancer Institute, Boston, Massachusetts, USA 2Harvard Medical School, Boston, Massachusetts, USA  \nCorrespondence to  \nDr Eliezer M Van Allen;  \neliezerm_vanallen@dfci. [harvard.edu](harvard.edu)  \nABSTRACT  \nImmuno-oncology holds promise for transforming patient care having achieved durable clinical response rates across a variety of advanced and metastatic cancers. Despite these achievements, only a minority of patients respond to immunotherapy, underscoring the importance of elucidating molecular mechanisms responsible for response and resistance to inform the development and selection of treatments. Breakthroughs in molecular sequencing technologies have led to the generation of an immense amount of genomic and transcriptomic sequencing data that can be mined to uncover complex tumor-immune interactions using computational tools. In this review, we discuss existing and emerging computational methods that contextualize the composition and functional state of the tumor microenvironment, infer the reactivity and clonal dynamics from reconstructed immune cell receptor repertoires, and predict the antigenic landscape for immune cell recognition. We further describe the advantage of multi-omics analyses for capturing multidimensional relationships and artificial intelligence techniques for integrating omics data with histopathological and radiological images to encapsulate patterns of treatment response and tumor-immune biology. Finally, we discuss key challenges impeding their widespread use and clinical application and conclude with future perspectives. We are hopeful that this review will both serve as a guide for prospective researchers seeking to use existing tools for scientific discoveries and inspire the optimization or development of novel tools to enhance precision, ultimately expediting advancements in immunotherapy that improve patient survival and quality of life.  \nBACKGROUND  \nThe concept of immuno-oncology, or modulating the immune system to treat cancer, can be traced back to over a century ago when Wilhelm Busch and Friedrich Fehleisen independently observed tumor regression inpatients with cancer after a superficial skin infection and subsequently intentionally inoculated other patients with cancer.1 Leveraging their work, William Coley treated patients with sarcoma with extracts of heat-inactivated Streptococcus pyogenes and Serratia marcescensand observed favorable responses.2 3 Lack of reproducibility and harmful side effects  \nhindered further use of Coley’s strategy but provided proof of concept for the use of cancer immunotherapies. Since then, numerous basic science investigations, along with novel experimental systems and technologies, have deepened our understanding of the relationship between the immune system and cancer cells and ascertained the immune system’s ability to eliminate malignant cells. Over the last 30 years, the foundational discoveries and subsequent clinical successes of novel immunotherapeutic modalities have revolutionized the field of oncology; yet, chal  \nlenges remain to maximize their potential.  \nDiscoveries in the late 1990s on the roles of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and programmed cell death 1 ","cbCaieNVzo7JgS2L","https://ap.wps.com/l/cbCaieNVzo7JgS2L","pdf",2865904,18,"English","# Abstract\n# Background","[{\"question\":\"Why is understanding immunotherapy response and resistance important in immuno-oncology?\",\"answer\":\"Only a minority of patients respond to immunotherapy, so clarifying molecular mechanisms of response and resistance is needed to improve treatment development and selection.\"},{\"question\":\"How does computational science use sequencing data in immuno-oncology?\",\"answer\":\"Next-generation sequencing generates large genomic and transcriptomic datasets that can be mined with computational tools to uncover complex tumor-immune interactions.\"},{\"question\":\"What does the review highlight about multi-omics and AI approaches?\",\"answer\":\"It emphasizes the advantage of multi-omics analyses to capture multidimensional relationships and AI techniques to integrate omics data with histopathological and radiological images for understanding treatment response and tumor-immune biology.\"}]","Historical perspective and future directions: computational science in immuno-oncology - review | PDF",1790012774,45]